Research  >  About SRI  >  Scientist Profiles
Share:  
|
PAGE
MENU

Scientist profiles G-L

SRI Profiles

Kevin Imrie
Kevin Imrie

Affiliate scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room D4 74
Toronto, ON
M4N 3M5

Phone: 416-480-4592
Fax: 416-480-6191

Administrative Assistant: Claudette Chambers
Phone: 416-480-4592
Email: department.medicine@sunnybrook.ca

Education:

  • Hon. B.Sc., 1984, University of Ottawa, Canada
  • MD, 1988, University of Ottawa, Canada
  • FRCPC, 1991, internal medicine
  • FRCPC, 1993, hematology

Appointments and Affiliations:

Research Foci:

  • Competency-based education
  • Assessment of competency
  • Knowledge translation
  • Malignant hematology
  • Clinical trials

Research Summary:

Dr. Imrie’s principal research interest in recent years has been focused on educational research and scholarship with an emphasis on competency-based education and fatigue risk management and mitigation.

He has been active in clinical trials in malignant lymphoma. He has served as local or national principal investigator on major clinical trials in malignant lymphoma. He is a member of the National Cancer Institute of Canada hematology site group and was a member of the clinical trials group from 2009 to 2013.

A further area of research activity is practice guideline development and translation into practice. He has served as chair of the hematology disease site group for Cancer Care Ontario's program in evidence-based care. His work in this area resulted in seven published practice guidelines and influenced the funding of new cancer drugs in Ontario.

Selected Publications:

See current publications list at PubMed.

  1. Brydges R, Stroud L, Wong BM, Holmboe ES, Imrie K, Hatala R. Core competencies or a competent core? A scoping review and related synthesis of invasive bedside procedural skills training in internal medicine. Academic Medicine. 2017. (Link)
  2. Prica A, Baldassarre F, Hicks LK, Imrie K, Kouroukis T, Cheng M, members of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care. Rituximab in lymphoma and chronic lymphocytic leukaemia: a practice guideline. Clin Oncol. 2017. (Link)
  3. Lieff SJ, Zaretsky A, Bandiera G, Imrie K, Spadafora S, Glover Takahashi S. What do I do? Developing a competency inventory for postgraduate (residency) program directors. Medical Teacher 2016. (Link)
  4. Imrie KR, Frank JR, Parshuram C. Resident duty hours: past, present, and future. BMC Med Ed. 2014. (Link)
  5. Wilson J, Amit M, Fitzgerald W, Dagg P, Bullock G, Steeves J, Robbins N, Snell L, Imrie K. Generalism: achieving a balance with specialization. Royal College of Physicians and Surgeons of Canada. 2011 Jan. (Link)
  6. Imrie K, Deepak D, Bullock G, Maudsley RF, Wilson J, Jamal M, Fisher R, Saad N, Murhaghan A. The Resident's dual role as learner and service provider. Royal College of Physicians and Surgeon of Canada. 2011 Jan. (Link)
  7. Lankshear S, Brierley JD, Imrie K and Yurcan M. Changing physician practice: an evaluation of knowledge transfer strategies to enhance physician documentation of cancer stage. Healthc Q. 2010;13(1):84–92.
  8. Marcus R, Imrie K, Solal-Celigny P, Catalano JV, Dmoszynska A, Raposo JC, Offner FC, Gomez-Codina J, Belch A, Cunningham D, Wassner-Fritsch E and Stein G. Phase III study of R-CVP compared with cyclophosphamide, vincristine and prednisone alone in patients with previously untreated advanced follicular lymphoma. J Clin Oncol. 2008 Oct;26(28):4579–86.
  9. Hicks LK, Haynes AE, Reece DE, Walker IR, Herst JA, Meyer RM, Imrie K; Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care. A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma. Cancer Treat Rev. 2008 Aug;34(5):442–52.

Related News and Stories:

Related Links: